Cardioprotection by triiodothyronine following caloric restriction via long noncoding RNAs.


Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 21 06 2020
revised: 10 08 2020
accepted: 17 08 2020
pubmed: 18 9 2020
medline: 18 2 2021
entrez: 17 9 2020
Statut: ppublish

Résumé

Severe caloric-restriction compromises thyroid hormone (TH) status, apparently to save energy and proteins for enduring stress stimulus. However, a persistent decrease in TH levels may compromise heart function. We hypothesized that supplementation of low dose active TH or targeting hypoxia-inducible factor-1-alpha, HIF-1α (a strong activator of deiodinase enzyme that degrades peripheral active THs) will prevent deterioration of cardiac performance. Adult mice were subjected to acute fasting based on institutional animal protocols with ad libitum access to water. The following groups were studied: Control mice with free access to food; severe caloric restriction fasting only group; Fasting with Triiodo-l-Thyronine (T3); Fasting with HIF-1α inhibitor (BAY). Cardiac hemodynamic and electrophysiological studies were performed and role of long noncoding RNAs were explored. Following severe caloric-restriction, we found that body weights, and heart weights to a partial extent, were decreased. Low-dose T3 treatment attenuated left ventricular hemodynamic impairment in indices of cardiac contractility and relaxation. In electrophysiology studies, fasting mice developed atrial tachyarrhythmias upon induction. This reverted to control levels following T3 treatment. There was a significant increase in atrioventricular conduction time and significant decrease in heart rate following fasting. Both these changes were attenuated following T3 treatment. Furthermore, BAY partially improved hemodynamics. Compared to the severe caloric-restriction group, both T3 and BAY reduced MALAT1 and GAS5 long noncoding RNA expression. These new findings indicate that T3 and BAY protect from cardiac decompensation secondary to acute severe caloric-restriction partly mediated by long noncoding RNAs.

Identifiants

pubmed: 32942153
pii: S0753-3322(20)30850-7
doi: 10.1016/j.biopha.2020.110657
pii:
doi:

Substances chimiques

Cardiotonic Agents 0
RNA, Long Noncoding 0
Triiodothyronine 06LU7C9H1V

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110657

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

Viswanathan Rajagopalan (V)

New York Institute of Technology College of Osteopathic Medicine at A-State, 119 State University, Jonesboro, AR, United States. Electronic address: vrajagop@nyit.edu.

Mateusz Gorecki (M)

New York Institute of Technology College of Osteopathic Medicine at A-State, 119 State University, Jonesboro, AR, United States.

Clifford Costello (C)

New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, United States.

Emily Schultz (E)

New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, United States.

Youhua Zhang (Y)

New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, United States.

A Martin Gerdes (AM)

New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, United States.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH